Myeloma Canada funds research projects proposals that align with one or more of Myeloma Canada’s Funded Research Principles, demonstrating a clear and direct impact in at least one of the following areas:

• improving the quality of life and/or survival of people living with myeloma;
• increasing patient access to new myeloma therapies, novel treatment combinations, or improved approaches to treatment administration; and/or
• improving myeloma healthcare delivery, including systems, processes, or models of care.

Research proposals must also address one or more of the Top Ten Myeloma Research Priorities in Canada.

These gaps were identified through the Myeloma Priority Setting Partnership (PSP). The Myeloma PSP was a collaborative initiative involving Horizon Health Network, the Maritime SPOR SUPPORT UNIT (MSSU), and Myeloma Canada, and followed established PSP methodologies set out by the James Lind Alliance. Click here to read the published correspondence, “The future of myeloma research in Canada and beyond: results of a James Lind Alliance priority setting partnership”.